The top two articles on DAIC from 2019 included the FDA approval of two transcatheter aortic valve replacement (TAVR) systems for all surgical risk categories, making TAVR available to all patients based on recommendations by the heart team. The second biggest story of 2019 was the release of new atrial fibrillation guidelines recommend novel oral anticoagulants (NOACs) over the previous standard of care warfarin.

Here is the top cardiology content on the Diagnostic and Interventional Cardiology (DAIC) website from 2019 based on the analytics of its record 3.1 million pageviews. 

January 2, 2020 — In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease. EACTS leadership said the reason was because the results of the EXCEL randomized clinical trial were misleading because of the definitions used for myocardial infarction (MI).[1] 

This photo is from a MitraClip procedure during the University of Colorado visit last December.

Here are the top performing 25 videos posted to the DAIC website in the past year, based on Google Analytics. These the the top viewed videos based on more than 475,500 video pageviews in 2019.
 
1. VIDEO: Why Are There So Many Foreign Doctors? — William Pinsky, M.D., and Mandeep Mehra, M.D., medical director of the Brigham and Women’s Hospital (BWH) Heart and Vascular Center, explain the U.S. doctor shortage and how foreign doctors help fill the gap.

December 30, 2019 — Merit Medical Systems Inc., a leading manufacturer of proprietary devices used primarily in cardiology, radiology, oncology and endoscopy, announces the commercial launch of the PreludeSYNC EVO radial compression device in European, Middle Eastern and African markets.

The product has FDA clearance in the U.S. and CE Mark approval in the EU for use in diagnostic cardiac catheterisation procedures and percutaneous coronary interventions.

December 30, 2019 — Acoustoelectric cardiac imaging, a new, noninvasive cardiac imaging technology developed at the University of Arizona, has been licensed to startup ElectroSonix.

December 30, 2019 — A drug therapy targeting the production of a protein produced by the liver has led to sustained and significant reductions in triglyceride levels using low dosages. The findings were recently reported in a late-breaking presentation at the American Heart Association Scientific Sessions 2019 by Dr.

December 30, 2019 — Most patients do not understand or recall information given to them before heart procedures. For example, many patients mistakenly believe that opening blocked arteries will cure them of heart disease.

December 30, 2019 — Eko, a digital health company with an AI-powered cardiac screening platform, announced the second generation of its CORE product line. An evolution from Eko's first-generation CORE, the new CORE features powerful amplification and active noise cancellation that enables doctors and nurses to hear heart and lung sounds with greater clarity and screen patients for heart disease, the number one cause of death in the U.S., more effectively.

The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).

December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (Afib or AF).

World Best Global Heart Conference

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now